REFLOW THERAPEUTICS

ReFlow is pioneering in a novel approach for real-time diagnosis and treatment of the no-reflow phenomenon in acute heart attack and later heart failure patients. ReFlow’s medical system will allow for overcoming micro-vascular obstruction (MVO) and blockage in the very small blood supply vessels within the affected heart muscle in heart attack patients. ReFlow completed its proof-of-concept trials at the University Hospital of Zürich and filed provisional patent applications in Europe and the United States.